Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers
Gerald Bastian Schulz, Severin Rodler, Bernadett Szabados, Annabel Graser, Alexander Büchner, Christian G. Stief, Jozefina Casuscelli
Topics & Concepts
MedicineCommon Terminology Criteria for Adverse EventsInternal medicineIpilimumabPembrolizumabAtezolizumabNivolumabOncologyAdverse effectDysgeusiaPopulationRenal cell carcinomaGenitourinary systemCancerImmunotherapyEnvironmental healthCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatment